相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study
Clare White et al.
LANCET HAEMATOLOGY (2019)
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the 'select-d' Pilot Trial
A. Young et al.
THROMBOSIS RESEARCH (2018)
Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model
Michael Feehan et al.
THROMBOSIS RESEARCH (2018)
Patient relevant bleeding complications; it's bleeding complicated
Simon Noble
THROMBOSIS RESEARCH (2018)
Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study
B. Tardy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
The treatment of cancer associated thrombosis: does one size fit all? Who should get LMWH/warfarin/DOACs?
Simon Noble et al.
THROMBOSIS RESEARCH (2016)
Impact of a dedicated cancer-associated thrombosis service on clinical outcomes: a mixed-methods evaluation of a clinical improvement exercise
Simon Noble et al.
BMJ OPEN (2016)
A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
Janesh K. Gupta et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN Study
C. W. Francis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D. Farge et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
The prevention of hospital-acquired venous thromboembolism in the United Kingdom
Beverley J. Hunt
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
The challenges of managing cancer related venous thromboembolism in the palliative care setting
S. Noble
POSTGRADUATE MEDICAL JOURNAL (2007)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
分享论文
